Physician profile
David Fan
NPI 1467832113
$3,394.01
in general payments reported to CMS, 2019-2025
8 companies · $3,181 in 2025
The $3,181 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.64 · 2024: $177 · 2025: $3,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $290 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $289.88 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endolumik, INC. | $3,050.00 | 2025 | Endolumik Gastric Calibration Tube, Medical Device |
| Glaxosmithkline, LLC. | $109.44 | 2024 | Nucala |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Intuitive Surgical, INC. | $46.72 | 2022-2024 | |
| Baxter Healthcare | $42.65 | 2024 | Tisseel |
| Becton, Dickinson and Company | $36.58 | 2025 | |
| Davol INC. | $26.35 | 2025 | Phasix Mesh |
| Genzyme Corporation | $13.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.